Supernova Peptides
Back to catalog
Tirzepatide

METABOLIC · SNP-TIRZEPATIDE

Tirzepatide

Dual GIP/GLP-1 metabolic research. Lab grade.

$400

Lyophilized · Research grade

Tirzepatide's dual agonism of both GIP and GLP-1 receptors represents a significant advancement over single-pathway compounds in metabolic research. With one of the most extensively documented research profiles in its class, Tirzepatide is widely studied in laboratory settings. Supernova Peptides sources research-grade Tirzepatide with third-party COA verification — for in-vitro laboratory research only.

  • Advanced weight management research
  • Dual GIP/GLP-1 studies
  • Metabolic optimization
  • Insulin sensitivity research

Select size

1

Need batch documentation? Request COA

>99% HPLC verified purity

Cold-chain shipped in 48h

  • Third-party HPLC & mass-spec verified
  • Manufactured in an ISO-certified facility
  • Cold-chain shipped with insulated packaging

Specifications

Product
Tirzepatide
SKU
SNP-TIRZEPATIDE
Category
Wellness
Molecular weight / formula
~4,813.5 g/mol; C225H348N48O68
Storage
-20°C, protect from light
Status
FDA Approved

For research purposes only. This product is not intended to diagnose, treat, cure, or prevent any disease.

Related compounds

MOTS-C
METABOLIC

MOTS-C

Mitochondrial peptide. Metabolic pathway research.

$300

Retatrutide
METABOLIC

Retatrutide

The next generation of metabolic research.

From $400

Semaglutide
METABOLIC

Semaglutide

Extensively studied GLP-1 analog. Research grade.

$300